We use a whole-brain, data-driven approach to determine how the functional connectome predicts amyloid-β and tau PET binding in a preclinical Alzheimer’s disease cohort (the A4 study). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.